These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3373056)

  • 1. Investigation into the presence of Leishmania antibodies in patients with hepatosplenomegaly.
    Kabil SM; Morsy TA; Yousef SM
    J Egypt Soc Parasitol; 1988 Jun; 18(1):29-34. PubMed ID: 3373056
    [No Abstract]   [Full Text] [Related]  

  • 2. Serological and parasitological examination of some patients with manifestations suggestive leishmaniasis.
    Morsy TA; Kabil SM; Yousef SM; el Sadek MM; Lashin AH
    J Egypt Soc Parasitol; 1990 Jun; 20(1):35-46. PubMed ID: 2332662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the specificity of the indirect haemagglutination in diagnosis of visceral leishmaniasis.
    Morsy TA; Ahmed MM; Younis TA; Arafa MM
    J Egypt Soc Parasitol; 1990 Jun; 20(1):231-4. PubMed ID: 2332651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immune response of golden hamsters to Leishmania donovani as tested by immunoelectroadsorption.
    Mathot C; D'Alesandro PA; Scher S; Rothen A
    Am J Trop Med Hyg; 1967 Jul; 16(4):443-6. PubMed ID: 4952868
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody kinetics in kala-azar in response to treatment.
    Neogy AB; Nandy A; Ghosh Dastidar B; Chowdhury AB
    Ann Trop Med Parasitol; 1987 Dec; 81(6):727-9. PubMed ID: 2845873
    [No Abstract]   [Full Text] [Related]  

  • 6. Visceral leishmaniasis in Somalia. Circulating antibodies as measured by DAT, immunofluorescence and ELISA.
    Shiddo SA; Mohamed AA; Huldt G; Loftenius A; Nilsson L; Jonsson J; Ouchterlony O; Thorstensson R
    Trop Geogr Med; 1995; 47(2):68-73. PubMed ID: 8592766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of Leishmania donovani antibodies in past visceral leishmaniasis cases in India.
    Gidwani K; Picado A; Ostyn B; Singh SP; Kumar R; Khanal B; Lejon V; Chappuis F; Boelaert M; Sundar S
    Clin Vaccine Immunol; 2011 Feb; 18(2):346-8. PubMed ID: 21159922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental infection with Leishmania in the dog: clinical, pathologic, parasitologic and serologic findings].
    Pospischil A; Fiebiger I; Krampitz HE; Weiland G
    Zentralbl Veterinarmed B; 1987 Jun; 34(4):288-304. PubMed ID: 3673364
    [No Abstract]   [Full Text] [Related]  

  • 9. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
    Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S
    Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoantibodies and Leishmania infection].
    Julià Benique MR; Salvá F; Hernández M; Matamoros N
    Med Clin (Barc); 1991 Jun; 97(5):197-8. PubMed ID: 1921552
    [No Abstract]   [Full Text] [Related]  

  • 11. [The serological examination of the population for leishmaniasis and the detection of Leishmania in rodents in the Republic of Guinea].
    Kamara Bomba L; Saf'ianova VM; Goncharov DB; Emel'ianova LP
    Med Parazitol (Mosk); 1992; (2):42-6. PubMed ID: 1435540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of Leishmania donovani infection in household members residing with visceral leishmaniasis patients.
    Saran R; Gupta AK; Sharma MC
    J Commun Dis; 1992 Dec; 24(4):242-4. PubMed ID: 1344960
    [No Abstract]   [Full Text] [Related]  

  • 13. [The determination of the species specificity of Leishmania antibodies in different groups of human sera].
    Giboda M; Goncharov DB; Saf'ianova VM; Gracheva LI; Ditrich O
    Med Parazitol (Mosk); 1991; (3):29-32. PubMed ID: 1770880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre- and post-treatment antibody levels in visceral leishmaniasis.
    Hailu A
    Trans R Soc Trop Med Hyg; 1990; 84(5):673-5. PubMed ID: 2278067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmania-HIV co-infection: an emerging problem in India.
    Redhu NS; Dey A; Balooni V; Singh S
    AIDS; 2006 May; 20(8):1213-5. PubMed ID: 16691082
    [No Abstract]   [Full Text] [Related]  

  • 16. Visceral leishmaniasis and malaria prevalence in West Pokot District, Kenya.
    Mutero CM; Mutinga MJ; Ngindu AM; Kenya PR; Amimo FA
    East Afr Med J; 1992 Jan; 69(1):3-8. PubMed ID: 1628545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host humoral immune response to Leishmania lipid-binding protein.
    Maache M; Azzouz S; Diaz de la Guardia R; Alvarez P; Gil R; de Pablos LM; Osuna A
    Parasite Immunol; 2005 Jun; 27(6):227-34. PubMed ID: 16048642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serologic examination of the population of cleaned-up foci of visceral leishmaniasis in the territory of the Uzbek SSR].
    Nizamov BB; Tursunov SS; Razakov ShA; Gracheva LI; Saf'ianova VM
    Med Parazitol (Mosk); 1989; (6):28-31. PubMed ID: 2534148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-cell activating factor deficiency suppresses splenomegaly during Leishmania donovani infection.
    Omachi S; Fujii W; Azuma N; Morimoto A; Sanjoba C; Matsumoto Y; Goto Y
    Biochem Biophys Res Commun; 2017 Aug; 489(4):528-533. PubMed ID: 28583852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of anti-Leishmania donovani antibody among Brazilian blood donors and multiply transfused hemodialysis patients.
    Luz KG; da Silva VO; Gomes EM; Machado FC; Araujo MA; Fonseca HE; Freire TC; d'Almeida JB; Palatnik M; Palatnik-de Sousa CB
    Am J Trop Med Hyg; 1997 Aug; 57(2):168-71. PubMed ID: 9288810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.